References
- Velazquez C., Carlson A., Stokes K. Relative safety of mirtazepine overdose. Vet Hum Toxicol 2001; 43: 342–344
- Montgomery S. Safety of mirtazepine: a review. Int Clin Psychopharm 1995; 10: 37–45
- McDaniel M. W. Serotonin syndrome: early management with cyproheptadine. Ann Pharmacother 2001; 35: 870–873
- Tobin A., Unger W., Osbourne N. Evidence for the presence of serotonergic nerves and receptors in the iris‐ciliary body complex of the rabbit. J Neurosci 1988; 8: 3713–3721
- Palkama A., Lehtosalo J., Uusitalo H. 5‐hydroxytrypamine receptors in the cornea and ciliary processes of rabbit and human eyes. Ophthalmic Res 1984; 16: 14
- Fanciullacci M., Sicuteri R., Alessandri M., Gepetti P. Busipirone, but not sumatriptan, induces miosis in humans: relevance for a serotonergic pupil control. Clin Pharmacol Ther 1995; 57: 349–355
- Phillips M., Szabadi E., Bradshaw C. The effects of the novel anxiolytic drug lesopitron, a full and selective 5HT1A receptor agonist, on pupil diameter and oral temperature in man: comparision with buspirone. J Psychopharmacol 1999; 13: 391–397
- Blackburn T., Thornber C., Pearce R., Cox B. In vitro pharmacology of ICI 169,369, a chemically novel 5HT antagonist. Eur J Pharmacol 1988; 150: 247–256
- Millson D. Pupillometry as a pharmacodynamic assessment in clinical pharmacology. J Psychophysiol 1991; 5: 255–257